Cyclic & macrocyclic peptide discovery

Cyclic & Macrocyclic
Peptide Discovery Services

Connect target-focused design, screening, experimental validation and lead optimization in one discovery program.

Start with a target, a hit or an existing lead series. CD ComputaBio helps define the next molecular design and experimental decision around your intended application.

Structure-inspired illustration based on SFTI-1 (PDB 1JBL).

Home / Peptide Drug Design & Development / Cyclic & Macrocyclic Peptide Discovery

Choose your point of entry

Where Does Your Cyclic Peptide Program Start?

Cyclic peptide discovery develops constrained peptide molecules around a target or functional objective. Ring connectivity, stereochemistry and side-chain chemistry shape the accessible conformations and experimental behavior. A useful campaign connects those molecular choices with evidence from synthesis and testing.

Within our peptide drug design and development services, projects can begin at different stages. The paths below organize the work around your existing materials and the decision you need to make next.

01 / A TARGET WITHOUT A LIGAND

AI-Guided De Novo Design

Assess the target and binding region, explore constrained backbones and sequences, then prioritize chemically defined candidates for synthesis and testing.

Output: a first candidate set with structural hypotheses and testing priorities.

Explore De Novo Cyclic Peptide Design →
02 / A SCREEN OR CANDIDATE PANEL

Screening & Hit Validation

Plan target-focused library selection or evaluate existing candidates through independent preparation, binding confirmation and relevant biological assays.

Output: a hit panel with traceable chemical and experimental evidence.

Explore Screening & Hit Validation →
03 / A VALIDATED HIT OR SERIES

Cyclic Peptide Lead Optimization

Use focused analog design, synthesis and SAR to improve the activity, selectivity, stability or handling properties that limit your current lead.

Output: compared analogs, an integrated ranking and next-round recommendations.

Explore Lead Optimization →
04 / AN APPLICATION BRANCH

Radioligand Design & Optimization

Develop peptide targeting constructs around attachment sites, linkers and labeling units, with staged evaluation of recognition and distribution.

Output: defined conjugate options and an application-specific evaluation plan.

Explore Peptide Radioligand Design →

Not sure where to begin? Share your target, available sequences and current evidence. We will help identify the appropriate entry stage and initial work package.

Define the evidence your program needs

Set the Target, Molecular Format and Next Decision

Early planning aligns the molecular objective with practical materials and assays. We review target identity, species, domain boundaries, available structures and known ligands alongside the desired biological effect.

Projects may seek direct binding, competition, enzyme inhibition, receptor modulation or selective targeting. Each objective creates different requirements for candidate design, controls and functional confirmation. For existing molecules, complete chemical definitions and original assay conditions establish a comparable baseline.

Existing results are reviewed with their sample identity and experimental context. For example, enrichment data, a single-concentration assay response and an independently measured binding curve support different next steps. The project plan identifies which evidence can be used directly and which comparison needs confirmation.

The initial assessment turns these inputs into a staged plan with proposed computational and experimental modules, review points and deliverables.

Share a target, hit or lead-series summary →

Make the constraint part of the design

Connect Conformation, Binding and Chemical Feasibility

A macrocycle is defined by its complete connectivity. Sequence, ring size, stereochemistry and closure chemistry are considered together.

Conformational Questions

Explore plausible ring conformations, local flexibility and exposed polar or hydrophobic regions. Cyclic peptide modeling supports structural interpretation and the selection of hypotheses for testing.

Target Recognition

Evaluate the proposed binding region, contact residues and steric complementarity. Structural hypotheses help prioritize candidates while assay planning establishes how recognition will be assessed independently.

Chemical Definition

Include noncanonical residues, D-stereochemistry, backbone modifications and closure positions where relevant. Review building-block availability, synthesis routes and characterization needs before committing to a candidate panel.

Keep Candidate Diversity Informative

A first campaign can retain distinct backbone families or interaction hypotheses. Follow-up panels narrow the design space around evidence from experiments, allowing the next series to test specific molecular changes.

Move from a proposed molecule to interpretable evidence

Connect Synthesis, Characterization and Validation

PREPARE

Define and Make the Molecule

Review sequence, chirality, termini and ring connectivity. Scope candidate synthesis, cyclization, purification and analytical checks around the material needed for testing.

CONFIRM

Measure the Relevant Behavior

Use suitable binding and biological assays with appropriate references, repeats and background controls. Choose selectivity, competition or functional measurements around the intended use.

LEARN

Use Results to Direct the Next Set

Relate positive and negative findings to chemical structure, candidate quality and assay context. Nominate a focused follow-up experiment or a new analog series.

Library planning can involve a virtual design space, a chemically synthesized analog panel or an encoded display library. These formats answer different questions. Our peptide library design services help organize candidate composition and diversity; the screening and hit validation pathway connects discovery outputs with independent confirmation.

Synthesis quantities, purity specifications, analytical methods and assay modules are agreed in the project proposal. Complex connectivity or isomer questions may require additional characterization beyond mass and chromatographic purity.

Advance the series on a balanced profile

Optimize Activity, Selectivity and Developability Together

Optimization is organized around the properties that limit the next research step. Parent compounds and analogs are compared under suitable matched conditions so the chemical changes can be interpreted. A preferred series may balance several properties rather than maximize one measurement. Changes that improve affinity while reducing solubility, or extend exposure while increasing background retention, are reviewed against the intended use before another round is selected.

Program questionDesign and evaluation focusDecision evidence
Is activity sufficient?Contact residues, backbone geometry and ring constraints.Binding or functional comparisons appropriate to the target.
Is recognition selective?Differentiating substitutions and designated counter-targets.Comparative results within the agreed assay panel.
Is the molecule stable?Degradation-sensitive regions, stereochemistry and linkage changes.Stability measurements in relevant matrices.
Can the sample be handled reliably?Charge, hydrophobicity, aggregation and synthesis behavior.Solubility, analytical quality and material observations.
Does exposure fit the intended use?Stability, suitable long-acting modifications and staged PK work.Retained activity together with exposure-related results.

Cyclic peptide lead optimization connects analog design, synthesis, SAR and experimental feedback.

Peptide developability prediction supports computational triage and the prioritization of property studies.

Select the branch around the application

Develop the Molecular Profile Your Program Needs

THERAPEUTIC DISCOVERY

Binders & Modulators

Build starting points for receptor, extracellular protein, enzyme or PPI research. Prioritize recognition and the biological effect before expanding the optimization objectives.

IMAGING & TARGETED RADIATION RESEARCH

Peptide Radioligands

Consider the vector, linker and labeling unit as an integrated construct, then define recognition, stability and distribution studies.

Plan a Radioligand Program →
CONJUGATES & TOOLS

Targeting Ligands & Research Probes

Identify attachment-tolerant positions and compare the parent with labeled or conjugated formats. Uptake and retention studies can follow when required by the application.

Explore Peptide Modification →
ORAL DEVELOPMENT BRANCH

Oral Cyclic Peptides

Address intestinal stability, permeability, conformational behavior and oral-exposure questions through a dedicated development pathway.

Explore Oral Cyclic Peptide Services ↗

Application-specific work follows the evidence available for the starting ligand. Radioligand and oral-development projects are separate branches selected by the program objective.

Enter where your evidence begins

Build a Stage-Gated Discovery Program

The workflow connects discovery and optimization while allowing projects to begin with existing candidates or validated leads. Each stage ends with a defined output and a review of the next decision. Candidate diversity, analytical quality and assay readiness are considered at these transitions, helping concentrate subsequent work on comparisons that are informative for the program.

01

Scope

Review target, materials, data and application.

Output: project route and criteria.
02

Discover

Design, screen or assess an existing candidate set.

Output: nominated candidates.
03

Make & Validate

Prepare, characterize and independently test.

Output: reproducible hit evidence.
04

Optimize

Integrate SAR, selectivity and property studies.

Output: prioritized lead series.
05

Advance

Define follow-up studies around the intended use.

Output: next-stage research plan.

Review points help determine whether to refine the current scaffold, investigate an assay-dependent result, test another family or proceed with an application-specific construct.

Outputs linked to the project question

Receive a Traceable Discovery Package

✓

Project Assessment & Plan

Starting evidence, development objective, recommended modules and stage criteria.

✓

Defined Candidate or Analog Set

Sequences, stereochemistry, modifications, ring connectivity and sample identifiers.

✓

Models & Design Rationale

Relevant structural hypotheses, prioritization logic and supporting analysis.

✓

Materials & Analytical Records

Contracted samples, batch information and agreed characterization results.

✓

Experimental Results & Comparisons

Agreed assay outputs, controls, conditions and compound-level interpretation.

✓

Integrated Next-Step Report

Candidate ranking, remaining questions and recommendations for further work.

Choose a focused computational task, a design-plus-experiment package or a staged iterative program. Scope, candidate counts and experimental depth are defined around the decision you need to make. Deliverables preserve the distinction between design hypotheses, analytical observations and measured biological results, so chemistry and biology teams can review the same candidate record.

Published methods in perspective

Connect Molecular Design with Testable Candidates

RFpeptides research illustrates a workflow linking macrocycle backbone generation, sequence design and structural assessment. The figure provides a published example of how computational stages can be organized before candidate testing.1

Published RFpeptides workflow showing macrocycle generation, sequence design and structural evaluation
Macrocycle generation, sequence design and structural assessment in a published discovery workflow.1

Designing Protein-Binding Macrocycles

Explore how a published generative workflow connects target information with constrained peptide candidates.

Read the RFpeptides Analysis →

Planning your program

Frequently Asked Questions

Can a project begin without a peptide sequence?

Yes. Target and site assessment can establish a route through design or screening, followed by synthesis and confirmation of selected candidates.

Can existing candidates enter testing directly?

Yes. Share complete chemical definitions and supporting data. The initial scope can focus on material qualification, independent binding or functional confirmation.

Can the project include noncanonical residues?

Residue chemistry, stereochemistry and closure strategies are evaluated against modeling support, synthesis feasibility and the assay objective.

How is the starting stage chosen?

We review the current evidence and the next decision. A screening output, an independently validated hit and a mature analog series typically need different work packages.

Can a lead continue into radioligand development?

Yes. Attachment-site and conjugate design can follow suitable ligand evidence, with labeling chemistry and experimental modules scoped for the application.

Where are oral-development questions addressed?

The oral cyclic peptide pathway focuses on permeability, intestinal stability and oral exposure, connected to the shared discovery and optimization capabilities.

Your next discovery decision starts here

Bring Your Target, Hit or Lead Series.
Define Your Next Step.

Share the target, available structures or sequences, existing experimental results, intended application and main performance gap. We will help define a practical starting stage and project scope.

For structures and supporting files, email contact@computabio.com.

References

  1. Rettie, S. A.; Juergens, D.; Adebomi, V.; et al. Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. Nature Chemical Biology 2025, 21, 1948–1956. doi:10.1038/s41589-025-01929-w. Figure 1 reproduced under CC BY 4.0.
  2. Korsinczky, M. L. J.; et al. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. Journal of Molecular Biology 2001, 311, 579–591. Structural coordinates: PDB 1JBL.

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk